Sveriges mest populära poddar
Infectious Disease Puscast

Infectious Disease Puscast #64

29 min1 oktober 2024

On episode #64 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the weeks of 9/14 – 9/25/24.

Host: Daniel Griffin and Sara Dong

Subscribe (free): Apple PodcastsRSS, email

Become a patron of Puscast!

Links for this episode
  • Viral
  • Outcomes of Intravenous Immunoglobulin treatment of immunocompromised patients with viral respiratory infections (Annals of Allergy, Asthma & Immunology)
  • Comparative Emergence of Maribavir and Ganciclovir Resistance for Treatment of Cytomegalovirus Infection (JID)
  • Antibody persistence and safety of a live-attenuated chikungunya virus vaccine up to 2 years after single-dose administration in adults in the USA (LANCET Infectious Disease)
  • Bacterial
  • Determinant of 30-Day Mortality of Pulmonary Legionellosis (OFID)
  • Donor-derived bartonellosis in Solid Organ Transplant recipients (American Journal of Transplantation)
  • An Opt-Out Emergency Department Screening Intervention Leads to Major Increases in Diagnosis of Syphilis (OFID)
  • Fungal
  • The Last of US Season 2 (YouTube)
  • Fungal disease week (CDC)
  • Bridging Echinocandin with Azole antifungal Therapy On Prevention Of Invasive Candidiasis Post Lung Transplantation (OFID)
  • Early Introductions of Candida auris Detected by Wastewater Surveillance, Utah, USA, 2022–2023 (Emerging Infectious Diseases)
  • Parasitic
  • Toxoplasma gondii Infection of Alzheimer's Disease Mice Reduces Brain Amyloid Density Globally and Regionally (JID)
  • Miscellaneous
  • Effect of Social Distancing Caused by Heavy Snowfall on Seasonal Influenza Epidemic in a Local Region in Japan (Pediatric Infectious Disease Journal)

Music is by Ronald Jenkees

Information on this podcast should not be considered as medical advice.

Fler avsnitt av Infectious Disease Puscast

Visa alla avsnitt av Infectious Disease Puscast

Infectious Disease Puscast med Vincent Racaniello finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.